Format
Sort by
Items per page

Send to

Choose Destination

Links from Nucleotide

Items: 1 to 20 of 209

1.

Claudin-18 inhibits cell proliferation and motility mediated by inhibition of phosphorylation of PDK1 and Akt in human lung adenocarcinoma A549 cells.

Shimobaba S, Taga S, Akizuki R, Hichino A, Endo S, Matsunaga T, Watanabe R, Yamaguchi M, Yamazaki Y, Sugatani J, Ikari A.

Biochim Biophys Acta. 2016 Jun;1863(6 Pt A):1170-8. doi: 10.1016/j.bbamcr.2016.02.015.

PMID:
26919807
2.
3.

A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.

Kırlı K, Karaca S, Dehne HJ, Samwer M, Pan KT, Lenz C, Urlaub H, Görlich D.

Elife. 2015 Dec 17;4. pii: e11466. doi: 10.7554/eLife.11466.

4.

AMIGO2, a novel membrane anchor of PDK1, controls cell survival and angiogenesis via Akt activation.

Park H, Lee S, Shrestha P, Kim J, Park JA, Ko Y, Ban YH, Park DY, Ha SJ, Koh GY, Hong VS, Mochizuki N, Kim YM, Lee W, Kwon YG.

J Cell Biol. 2015 Nov 9;211(3):619-37. doi: 10.1083/jcb.201503113.

5.

PDK1 is Expressed in Ovarian Serous Carcinoma and Correlates with Improved Survival in High-grade Tumors.

Lohneis P, Darb-Esfahani S, Dietel M, Braicu I, Sehouli J, Arsenic R.

Anticancer Res. 2015 Nov;35(11):6329-34.

PMID:
26504072
6.

A human interactome in three quantitative dimensions organized by stoichiometries and abundances.

Hein MY, Hubner NC, Poser I, Cox J, Nagaraj N, Toyoda Y, Gak IA, Weisswange I, Mansfeld J, Buchholz F, Hyman AA, Mann M.

Cell. 2015 Oct 22;163(3):712-23. doi: 10.1016/j.cell.2015.09.053.

7.
8.

Phosphoinositide-dependent kinase-1 inhibits TRAF6 ubiquitination by interrupting the formation of TAK1-TAB2 complex in TLR4 signaling.

Moon G, Kim J, Min Y, Wi SM, Shim JH, Chun E, Lee KY.

Cell Signal. 2015 Dec;27(12):2524-33. doi: 10.1016/j.cellsig.2015.09.018.

PMID:
26432169
9.

Overexpression of 3-phosphoinositide-dependent protein kinase-1 is associated with prognosis of gastric carcinoma.

Bai X, Li P, Xie Y, Guo C, Sun Y, Xu Q, Zhao D.

Tumour Biol. 2016 Feb;37(2):2333-9. doi: 10.1007/s13277-015-4024-8.

PMID:
26373731
10.

PDK1 induces JunB, EMT, cell migration and invasion in human gallbladder cancer.

Lian S, Shao Y, Liu H, He J, Lu W, Zhang Y, Jiang Y, Zhu J.

Oncotarget. 2015 Oct 6;6(30):29076-86. doi: 10.18632/oncotarget.4931.

11.

MiR-454 inhibited cell proliferation of human glioblastoma cells by suppressing PDK1 expression.

Fang B, Zhu J, Wang Y, Geng F, Li G.

Biomed Pharmacother. 2015 Oct;75:148-52. doi: 10.1016/j.biopha.2015.07.029.

PMID:
26297548
12.

A Novel Inhibitor of AKT1-PDPK1 Interaction Efficiently Suppresses the Activity of AKT Pathway and Restricts Tumor Growth In Vivo.

Mäemets-Allas K, Viil J, Jaks V.

Mol Cancer Ther. 2015 Nov;14(11):2486-96. doi: 10.1158/1535-7163.MCT-15-0281.

13.

PDK1: A signaling hub for cell migration and tumor invasion.

Gagliardi PA, di Blasio L, Primo L.

Biochim Biophys Acta. 2015 Dec;1856(2):178-88. doi: 10.1016/j.bbcan.2015.07.003. Review.

PMID:
26238471
14.

The BioPlex Network: A Systematic Exploration of the Human Interactome.

Huttlin EL, Ting L, Bruckner RJ, Gebreab F, Gygi MP, Szpyt J, Tam S, Zarraga G, Colby G, Baltier K, Dong R, Guarani V, Vaites LP, Ordureau A, Rad R, Erickson BK, Wühr M, Chick J, Zhai B, Kolippakkam D, Mintseris J, Obar RA, Harris T, Artavanis-Tsakonas S, Sowa ME, De Camilli P, Paulo JA, Harper JW, Gygi SP.

Cell. 2015 Jul 16;162(2):425-40. doi: 10.1016/j.cell.2015.06.043.

15.

MiR-138 suppresses airway smooth muscle cell proliferation through the PI3K/AKT signaling pathway by targeting PDK1.

Liu Y, Yang K, Sun X, Fang P, Shi H, Xu J, Xie M, Li M.

Exp Lung Res. 2015;41(7):363-9. doi: 10.3109/01902148.2015.1041581.

PMID:
26151666
16.

miR-138-1* regulates aflatoxin B1-induced malignant transformation of BEAS-2B cells by targeting PDK1.

Wang Y, Zhang Z, Wang H, Zhang Y, Ji M, Xu H, Wang C, Sun Z, Gao W, Wang SL.

Arch Toxicol. 2016 May;90(5):1239-49. doi: 10.1007/s00204-015-1551-4.

PMID:
26084420
17.

Expression of 3-phosphoinositide-dependent protein kinase 1 in colorectal cancer as a potential therapeutic target.

Xu Z, Liao B, Zhang R, Yao J, Shi R, Wang L.

Med Oncol. 2015 Jul;32(7):198. doi: 10.1007/s12032-015-0645-4.

PMID:
26055151
18.

Phospho-tyrosine dependent protein-protein interaction network.

Grossmann A, Benlasfer N, Birth P, Hegele A, Wachsmuth F, Apelt L, Stelzl U.

Mol Syst Biol. 2015 Mar 26;11(3):794. doi: 10.15252/msb.20145968.

19.

PDK1 is a potential therapeutic target against angiosarcoma cells.

Wada M, Horinaka M, Yasuda S, Masuzawa M, Sakai T, Katoh N.

J Dermatol Sci. 2015 Apr;78(1):44-50. doi: 10.1016/j.jdermsci.2015.01.015.

PMID:
25726712
20.

PDK1 and SGK3 Contribute to the Growth of BRAF-Mutant Melanomas and Are Potential Therapeutic Targets.

Scortegagna M, Lau E, Zhang T, Feng Y, Sereduk C, Yin H, De SK, Meeth K, Platt JT, Langdon CG, Halaban R, Pellecchia M, Davies MA, Brown K, Stern DF, Bosenberg M, Ronai ZA.

Cancer Res. 2015 Apr 1;75(7):1399-412. doi: 10.1158/0008-5472.CAN-14-2785.

Supplemental Content

Support Center